,trastuzumab deruxtecan
biogen,daiichi sankyo,astrazeneca
['breast', 'enhertu', 'biogen']
enhertu raises the bar in breast cancer at #asco22 headlines biocentury's latest podcast. plus new life for her3, takeaways from 's asco chat w/ , s latest #als data &amp; 's adcomm fix 
The leading voice for decision-makers throughout the global biopharma ecosystem. 
Free weekly podcast "BioCentury This Week": https://t.co/6CfHh0mIT6